rs114111020
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001364171.2(ODAD1):c.1636G>A(p.Ala546Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00177 in 1,600,422 control chromosomes in the GnomAD database, including 44 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001364171.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ODAD1 | NM_001364171.2 | c.1636G>A | p.Ala546Thr | missense_variant | 16/16 | ENST00000674294.1 | NP_001351100.1 | |
ODAD1 | NM_144577.4 | c.1525G>A | p.Ala509Thr | missense_variant | 14/14 | NP_653178.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ODAD1 | ENST00000674294.1 | c.1636G>A | p.Ala546Thr | missense_variant | 16/16 | NM_001364171.2 | ENSP00000501363.1 |
Frequencies
GnomAD3 genomes AF: 0.00894 AC: 1360AN: 152096Hom.: 17 Cov.: 33
GnomAD3 exomes AF: 0.00237 AC: 546AN: 230062Hom.: 7 AF XY: 0.00172 AC XY: 217AN XY: 126462
GnomAD4 exome AF: 0.00102 AC: 1476AN: 1448208Hom.: 27 Cov.: 62 AF XY: 0.000933 AC XY: 672AN XY: 720558
GnomAD4 genome AF: 0.00895 AC: 1363AN: 152214Hom.: 17 Cov.: 33 AF XY: 0.00869 AC XY: 647AN XY: 74424
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 14, 2016 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 01, 2022 | See Variant Classification Assertion Criteria. - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Primary ciliary dyskinesia 20 Benign:1
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Aug 16, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at